
Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
Author(s) -
Jean-Christophe Lagier,
Matthieu Million,
Sébastien Cortaredona,
Léa Delorme,
Philippe Colson,
PierreEdouard Fournier,
Philippe Brouqui,
Didier Raoult,
Philippe Parola
Publication year - 2022
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s364022
Subject(s) - medicine , hydroxychloroquine , azithromycin , context (archaeology) , retrospective cohort study , intensive care unit , cohort , pediatrics , covid-19 , disease , antibiotics , paleontology , infectious disease (medical specialty) , microbiology and biotechnology , biology
We evaluated the 6-week mortality of SARS-CoV-2 hospitalized patients treated using a standardized protocol in 2020 in Marseille, France.